Contribution of Topoisomerase IV and DNA Gyrase Mutations in Streptococcus pneumoniae to Resistance to Novel Fluoroquinolones

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 1999-08, Vol.43 (8), p.2000-2004
Hauptverfasser:	PESTOVA, E, BEYER, R, CIANCIOTTO, N. P, NOSKIN, G. A, PETERSON, L. R
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Infective Agents Anti-Infective Agents - pharmacology Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Antitubercular Agents - pharmacology Biological and medical sciences Ciprofloxacin - pharmacology DNA Gyrase DNA Topoisomerase IV DNA Topoisomerases, Type II DNA Topoisomerases, Type II - genetics DNA, Bacterial - genetics Drug Resistance, Microbial Fluoroquinolones Levofloxacin Mechanisms of Resistance Medical sciences Microbial Sensitivity Tests Mutation Naphthyridines - pharmacology Ofloxacin - pharmacology Pharmacology. Drug treatments Phenotype Streptococcus pneumoniae Streptococcus pneumoniae - drug effects Streptococcus pneumoniae - enzymology Streptococcus pneumoniae - genetics Streptococcus pneumoniae - isolation & purification Transformation, Bacterial
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!